Please use this identifier to cite or link to this item:
Title: Enhanced tumor cell killing by ultrasound after microtubule depolymerization
Authors: Singh, Aditi
Tijore, Ajay 
Margadant, Felix 
Simpson, Chloe
Chitkara, Deepak
Low, Boon Chuan 
Sheetz, Michael 
Keywords: apoptosis
cancer therapy
mechanical forces
Issue Date: 11-Jun-2021
Publisher: John Wiley and Sons Inc
Citation: Singh, Aditi, Tijore, Ajay, Margadant, Felix, Simpson, Chloe, Chitkara, Deepak, Low, Boon Chuan, Sheetz, Michael (2021-06-11). Enhanced tumor cell killing by ultrasound after microtubule depolymerization. Bioengineering and Translational Medicine 6 (3) : e10233. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Recent studies show that tumor cells are vulnerable to mechanical stresses and undergo calcium-dependent apoptosis (mechanoptosis) with mechanical perturbation by low-frequency ultrasound alone. To determine if tumor cells are particularly sensitive to mechanical stress in certain phases of the cell cycle, inhibitors of the cell-cycle phases are tested for effects on mechanoptosis. Most inhibitors show no significant effect, but inhibitors of mitosis that cause microtubule depolymerization increase the mechanoptosis. Surprisingly, ultrasound treatment also disrupts microtubules independent of inhibitors in tumor cells but not in normal cells. Ultrasound causes calcium entry through mechanosensitive Piezo1 channels that disrupts microtubules via calpain protease activation. Myosin IIA contractility is required for ultrasound-mediated mechanoptosis and microtubule disruption enhances myosin IIA contractility through activation of GEF-H1 and RhoA pathway. Further, ultrasound promotes contractility-dependent Piezo1 expression and localization to the peripheral adhesions where activated Piezo1 allows calcium entry to continue feedback loop. Thus, the synergistic action of ultrasound and nanomolar concentrations of microtubule depolymerizing agents can enhance tumor therapies. © 2021 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.
Source Title: Bioengineering and Translational Medicine
ISSN: 2380-6761
DOI: 10.1002/btm2.10233
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1002_btm2_10233.pdf11.89 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons